The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Rouan Sarah Kathryn since 2019.
This trader's CIK number is 1761366.
At the time of last reporting, Rouan Sarah Kathryn was the Officer of Viking Therapeutics, Inc.. (stock ticker symbol VKTX).
Also see all insider trading activities at Viking Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | NAVB | 3,350 | $4,904 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | VKTX | 1,240 | $29,942 | 0 | $0 | 0 | $0 |
| 2024 | VKTX | 0 | $0 | 66,000 | $2,282,540 | 66,000 | $511,280 |
1. Navidea Biopharmaceuticals, Inc. (NAVB)
2. Viking Therapeutics, Inc. (VKTX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-05-17 | NAVB | Buy | 3,350 | 1.46 | 4,904 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-31 | VKTX | Buy | 1,240 | 24.15 | 29,942 |
| 2024-10-25 | VKTX | Option Ex | 11,000 | 4.88 | 53,680 |
| 2024-10-25 | VKTX | Sale | 11,000 | 80.89 | 889,790 |
| 2024-02-08 | VKTX | Sale | 25,000 | 28.05 | 701,250 |
| 2024-02-08 | VKTX | Option Ex | 25,000 | 8.32 | 208,000 |
| 2024-01-19 | VKTX | Sale | 30,000 | 23.05 | 691,500 |
| 2024-01-19 | VKTX | Option Ex | 30,000 | 8.32 | 249,600 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rouan Sarah Kathryn (Officer of Viking Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.